Literature DB >> 23880984

Differential expression of dipeptidyl peptidase IV in human versus cynomolgus monkey skin eccrine sweat glands.

Serafino Pantano1, Valérie Dubost, Katy Darribat, Philippe Couttet, Olivier Grenet, Steven Busch, Pierre Moulin.   

Abstract

Dipeptidyl peptidase IV (DPP4) is a peptidase whose inhibition is beneficial in Type II diabetes treatment. Several evidences suggest potential implication of DPP4 in skin disorders such as psoriasis, keloids and fibrotic skin diseases where its inhibition could also be beneficial. DPP4 expression in human skin was described mainly in dermal fibroblasts and a subset of keratinocytes in the basal layer. Of importance in the perspective of preclinical experimentation, DPP4 distribution in skin of non-human primate species has not been documented. This report evidences unexpected differences between a set of human and cynomolgus monkey skin samples revealing a major expression of DPP4 in eccrine sweat glands of cynomolgus monkeys but not in humans. This represents a unique distinctive feature compared to the conserved expression of dipeptidyl peptidases 8 and 9 and potential relevant DPP4 substrates such as neuropeptide Y (NPY) and receptors (NPY-receptor 1 and Neurokinin receptor). Finally the observation that cathepsin D, an unrelated protease, shows the opposite expression compared to DPP4 (present in human but not in cynomolgus monkey eccrine sweat glands) could indicate that human eccrine sweat glands evolved a divergent protease repertoire compared to non-human primates. These unexpected differences in the eccrine sweat glands protease repertoire will need to be confirmed extending the analysis to a major number of donors but could imply possible biochemical divergences, reflecting the functional evolution of the glands and the control of their activity. Our findings also demonstrate that non-human primates studies aiming at understanding DPP4 function in skin biology are not readily translatable to human.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23880984     DOI: 10.1007/s10735-013-9524-5

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  28 in total

1.  Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

Authors:  Maria Grazia Narducci; Enrico Scala; Antonella Bresin; Elisabetta Caprini; Maria Cristina Picchio; Daniele Remotti; Gianluca Ragone; Francesca Nasorri; Marina Frontani; Diego Arcelli; Stefano Volinia; Giuseppe Alfonso Lombardo; Giannandrea Baliva; Monica Napolitano; Giandomenico Russo
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

2.  Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis.

Authors:  P Savoia; M Novelli; A De Matteis; A Verrone; M G Bernengo
Journal:  J Cutan Pathol       Date:  1998-02       Impact factor: 1.587

3.  Blood, sweat, and chemotactic cytokines.

Authors:  P M Murphy
Journal:  J Leukoc Biol       Date:  1995-03       Impact factor: 4.962

Review 4.  Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.

Authors:  Joshua J Neumiller; Lindy Wood; R Keith Campbell
Journal:  Pharmacotherapy       Date:  2010-05       Impact factor: 4.705

5.  The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices.

Authors:  Giulio Ghersi; Qiang Zhao; Monica Salamone; Yunyun Yeh; Stanley Zucker; Wen-Tien Chen
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 6.  Role of CD26/dipeptidyl peptidase IV in human T cell activation and function.

Authors:  Kei Ohnuma; Nozomu Takahashi; Tadanori Yamochi; Osamu Hosono; Nam H Dang; Chikao Morimoto
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

Authors:  Roger Yazbeck; Gordon S Howarth; Catherine A Abbott
Journal:  Trends Pharmacol Sci       Date:  2009-11       Impact factor: 14.819

8.  Interleukin-1 alpha in human sweat is functionally active and derived from the eccrine sweat gland.

Authors:  K Sato; F Sato
Journal:  Am J Physiol       Date:  1994-03

9.  Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.

Authors:  Anja Thielitz; Robert W Vetter; Bianca Schultze; Sabine Wrenger; Luca Simeoni; Siegfried Ansorge; Klaus Neubert; Jürgen Faust; Petra Lindenlaub; Harald P M Gollnick; Dirk Reinhold
Journal:  J Invest Dermatol       Date:  2007-10-18       Impact factor: 8.551

10.  Normal human sweat contains interleukin-8.

Authors:  A P Jones; L M Webb; A O Anderson; E J Leonard; A Rot
Journal:  J Leukoc Biol       Date:  1995-03       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.